Directorio de personas
Antonio Garcia Guiñon

Antonio Garcia Guiñon

Grado: Licenciado/a

973 705351
agarciag.lleida.ics(ELIMINAR)@gencat.cat

Grupos

Publicaciones

  • Granell, Miquel; Calvo, Xavier; Garcia-Guinon, Antoni; Escoda, Lourdes; Abella, Eugenia; Ma Martinez, Clara; Teixido, Montserrat; Teresa Gimenez, Ma; Senin, Alicia; Sanz, Patricia; Campoy, Desiree; Vicent, Ana; Arenillas, Leonor; Rosinol, Laura; Sierra, Jorge; Blade, Joan; Fernandez de Larrea, Carlos

    Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition

    HAEMATOLOGICA 102 1099-1104. .

    [doi:10.3324/haematol.2016.158303]

  • Jose Cruz-Jentoft, Alfonso; Gonzalez, Bernardo; de la Rubia, Javier; Hernandez Rivas, Jose Angel; Alfonso Soler, Juan; Fernandez Lago, Carlos; Arnao, Mario; Gironella, Mercedes; Perez Persona, Ernesto; Teresa Zudaire, Maria; Olivier, Carmen; Altes, Alberto; Garcia Guinon, Antonio; Nomdedeu, Benet; Arnan, Montserrat; Ramirez Payer, Angel; Sanchez-Godoy, Pedro; Pajuelo, Nuria; Vilanova, David; Fernanez Monjil, Diego; Bonanad, Santiago

    Further psychometric validation of the GAH scale: Responsiveness and effect size

    JOURNAL OF GERIATRIC ONCOLOGY 8 211-215. .

    [doi:10.1016/j.jgo.2016.12.008]

  • Cabezon, M.; Bargay, J.; Xicoy, B.; Garcia, O.; Tormo, M.; Palomo, L.; Marce, S.; Valcarcel, D.; Pedro, C.; Jimenez, M. J.; Borras, J.; Guardia, R.; Brunet, S.; Marti, J. M.; Garcia, A.; Zamora, L.

    TP53 MUTATIONS IN HIGH RISK MYELODYSPLASTIC SYNDROMES PATIENTS TREATED WITH AZACITIDINE ACCORDING TO CETLAM GROUP PROTOCOL

    LEUKEMIA RESEARCH 55 155-155. .

    [doi:10.1016/S0145-2126(17)30383-1]

  • Ribera JM; García O; Oriol A; Gil C; Montesinos P; Bernal T; González-Campos J; Lavilla E; Ribera J; Brunet S; Martínez MP; Tormo M; Genescà E; Barba P; Sarrà J; Monteserín MC; Soria B; Colorado M; Cladera A; García-Guiñón A; Calbacho M; Serrano A; Ortín X; Pedreño M; Amigo ML; Escoda L; Feliu E

    Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group

    LEUKEMIA RESEARCH 41 12-20. .

    [doi:10.1016/j.leukres.2015.11.012]

  • García-Dabrio MC; Hoyos M; Brunet S; Tormo M; Ribera JM; Esteve J; Gallardo D; Duarte RF; de Llano MP; Bargay J; Martí-Tutusaus JM; Heras I; Garcia A; Salamero O; Aventin A; Lecrevisse Q; Orfao A; Sierra J; Nomdedéu JF

    Complex Measurements May Be Required to Establish the Prognostic Impact of Immunophenotypic Markers in AML

    AMERICAN JOURNAL OF CLINICAL PATHOLOGY 144 484-492. .

    [doi:10.1309/AJCPRL6XSVFMLH9V]

  • Bonanad S; De la Rubia J; Gironella M; Pérez Persona E; González B; Fernández Lago C; Arnan M; Zudaire M; Hernández Rivas JA; Soler A; Marrero C; Olivier C; Altés A; Valcárcel D; Hernández MT; Oiartzabal I; Fernández Ordoño R; Arnao M; Esquerra A; Sarrá J; González-Barca E; González J; Calvo X; Nomdedeu M; García Guiñón A; Ramírez Payer A; Casado A; López S; Durán M; Marcos M; Cruz-Jentoft AJ; GAH Group

    Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale

    JOURNAL OF GERIATRIC ONCOLOGY 6 353-361. .

    [doi:10.1016/j.jgo.2015.03.003]

  • Nomdedeu, J. F.; Hoyos, M.; Carricondo, M.; Bussaglia, E.; Estivill, C.; Esteve, J.; Tormo, M.; Duarte, R.; Salamero, O.; de Llano, M. P. Q.; Garcia, A.; Bargay, J.; Heras, I.; Marti-Tutusaus, J. M.; Llorente, A.; Ribera, J. M.; Gallardo, D.; Aventin, A.; Brunet, S.; Sierra, J.; CETLAM Grp

    Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML

    Leukemia 27 2157-2164. .

    [doi:10.1038/leu.2013.111]

  • Perez-Garcia, A.; Brunet, S.; Berlanga, J. J.; Tormo, M.; Nomdedeu, J.; Guardia, R.; Ribera, J. M.; Heras, I.; Llorente, A.; Hoyos, M.; Esteve, J.; Besalduch, J.; Bueno, J.; Sierra, J.; Gallardo, D.; Grp Cooperativo El Estudio & Trata

    CTLa-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy

    Leukemia 23 486-491. .

    [doi:10.1038/leu.2008.339]

  • Granell, M; Senin, A; Barata, A; Cibeira, MT; Gironella, M; Lopez-Pardo, J; Motllo, C; Garcia-Guinon, A; Ben-Azaiz, R; Abella, E; Soler, A; Canet, M; Marti, JM; Martino, R; Sierra, J; de Larrea, CF; Oriol, A; Rosinol, L; Study Myeloma Amyloidosis Cataloni

    Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma

    Bone Marrow Transplantation -. .

    [doi:10.1038/s41409-021-01429-0]

  • Villalba, A; Gonzalez-Rodriguez, AP; Arzuaga-Mendez, J; Puig, N; Arnao, M; Arguinano, JM; Jimenez, M; Canet, M; Teruel, AI; Sola, M; Diaz, FJ; Encinas, C; Garcia, A; Rosinol, L; Suarez, A; Gonzalez, MS; Izquierdo, I; Hernandez, MT; Infante, MS; Sanchez, MJ; Sampol, A; de la Rubia, J

    Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)

    LEUKEMIA & LYMPHOMA -. .

    [doi:10.1080/10428194.2022.2123229]